Suppr超能文献

假定的多巴胺D3受体激动剂(+)-PD 128907的辨别性刺激特性:突触前多巴胺D2自身受体的作用

Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors.

作者信息

Bristow L J, Cook G P, Patel S, Curtis N, Mawer I, Kulagowski J J

机构信息

Merck, Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, UK.

出版信息

Neuropharmacology. 1998 Jun;37(6):793-802. doi: 10.1016/s0028-3908(98)00066-5.

Abstract

The putative D3 receptor agonist, (+)-PD 128907, is widely used to study the functional relevance of D3 receptors in vivo. Given that non-selective D2/3/4 receptor agonists serve as effective discriminative stimuli in rats we have trained animals to discriminate (+)-PD 128907 (30 microg kg(-1), s.c.) from saline and examined the pharmacological specificity of the response. Consistent with a D3 receptor mediated response, the non-selective D2/3 receptor agonist apomorphine and the D3 preferring agonists 7-OH-DPAT and (-) quinpirole generalised to the cue whilst the D2/3 receptor antagonists haloperidol, raclopride, spiperone and (+)-butaclamol antagonised drug lever responding. In contrast, the D1 selective agonist (+/-)-SKF 81297 and D1/5 selective antagonist, R-(+)-SCH 23390 had no effect. Results also suggest that presynaptic dopamine receptors are involved. Thus the dopamine depleting agent alpha-methyl-p-tyrosine potentiated the effects of a submaximal dose of (+)-PD 128907 whereas amphetamine failed to generalise per se and blocked (+)-PD 128907 lever selection. However, studies using subtype selective antagonists argue against a role for the D3 receptor. Thus the 10-fold selective D2 receptor antagonist L-741,626 blocked the (+)-PD 128907 discriminative stimulus whereas L-745,829 and GR 103,691, antagonists > 40 and > 100-fold selective for D3 receptors, failed to modify the response. These results suggest that presynaptic D2 receptors mediate the discriminative stimulus properties of (+)-PD 128907 and highlight the lack of selectivity of (+)-PD 128907 for D3 receptors in vivo.

摘要

假定的D3受体激动剂(+)-PD 128907被广泛用于研究体内D3受体的功能相关性。鉴于非选择性D2/3/4受体激动剂在大鼠中可作为有效的辨别性刺激物,我们训练动物区分(+)-PD 128907(30微克/千克,皮下注射)和生理盐水,并研究了反应的药理学特异性。与D3受体介导的反应一致,非选择性D2/3受体激动剂阿扑吗啡以及更倾向于D3的激动剂7-羟基-DPAT和(-)喹吡罗可使反应泛化到该线索,而D2/3受体拮抗剂氟哌啶醇、雷氯必利、螺哌隆和(+)-丁酰苯则拮抗药物杠杆反应。相比之下,D1选择性激动剂(±)-SKF 81297和D1/5选择性拮抗剂R-(+)-SCH 23390则无作用。结果还表明,突触前多巴胺受体也参与其中。因此,多巴胺耗竭剂α-甲基-对-酪氨酸增强了次最大剂量(+)-PD 128907的作用,而苯丙胺本身未能使反应泛化且阻断了(+)-PD 128907的杠杆选择。然而,使用亚型选择性拮抗剂的研究反对D3受体起作用。因此,10倍选择性的D2受体拮抗剂L-741,626阻断了(+)-PD 128907的辨别性刺激,而对D3受体选择性大于40倍和大于100倍的拮抗剂L-745,829和GR 103,691未能改变该反应。这些结果表明,突触前D2受体介导了(+)-PD 128907的辨别性刺激特性,并突出了(+)-PD 128907在体内对D3受体缺乏选择性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验